Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis

Pharmacokinetics and Therapeutic Effect of OROS® Methylphenidate Under Different Breakfast Conditions in Children with Attention-Deficit/Hyperactivity Disorder

(2011) Sharon B. Wigal et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Model-Based Meta-Analysis of the Effect of Latanoprost Chronotherapy on the Circadian Intraocular Pressure of Patients With Glaucoma or Ocular Hypertension

(2010) K T Luu et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation

(2010) Jae Eun Ahn et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Disease progression meta-analysis model in Alzheimer's disease

(2009) Kaori Ito et al.   Alzheimers & Dementia

A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder

(2009) Matthew Brams et al.   CNS DRUGS

Efficacy and Safety of Extended-Release Dexmethylphenidate Compared with d,l-Methylphenidate and Placebo in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A 12-Hour Laboratory Classroom Study

(2008) Rafael Muniz et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY